A handful of recently published trials suggest that use of the pneumonia panel could lead to more targeted therapy delivered more quickly than standard methods.
The Global Pneumococcal Sequencing consortium found that non-vaccine-type bacteria increased after the introduction of pneumococcal conjugate vaccines.
In PNAS this week: signals of natural selection among Indigenous populations of North America, population and social structures of several European Stone Age burial sites, and more.
The BioFire FilmArray Pneumonia panel will be used to optimize clinical trial enrollment for an antibiotic to treat combat carbapenem-resistant A. baumannii infections.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.